Prothena Corp Public PRTA
NASDAQ PRTA
$9.73 +0.13 (+1.41%)
As of: Sep 4, 2026 · 1:35 PM EDT

Prothena Corp Public (PRTA) Net Cash Flow (2012 - 2026)

Prothena Corp Public (PRTA) posted quarterly Net Cash Flow of $21.9 million for Q1 2026, up 141.03% year-over-year from $9.1 million in Q1 2025, and up 194.08% quarter-over-quarter from -$23.3 million in Q4 2025.

Analysis

Prothena Corp Public (PRTA) Net Cash Flow (2012 - 2026) Analysis & Trends

Prothena Corp Public's Net Cash Flow history runs 15 years deep, the most recent figure standing at $21.9 million for Q1 2026.

  • In Q1 2026, Net Cash Flow rose 141.03% year-over-year to $21.9 million; the TTM figure through Mar 2026 stood at -$88.5 million (up 31.91% YoY), while the FY2025 annual figure was -$163.9 million, down 10.12% from the prior year.
  • Net Cash Flow for Q1 2026 stood at $21.9 million, up from -$23.3 million in the prior quarter.
  • The five-year high for Net Cash Flow was $215.6 million in Q4 2022, with the low at -$72.3 million in Q1 2024.
  • The 5-year median for Net Cash Flow is -$34.2 million (2022), against an average of -$14.7 million.
  • The sharpest annual moves came in 2022 and 2024: Net Cash Flow jumped 1126.65% in 2022, then plunged 480.64% in 2024.
  • Prothena Corp Public's Net Cash Flow stood at $215.6 million in 2022, then sank by 124.15% to -$52.1 million in 2023, then climbed by 8.05% to -$47.9 million in 2024, then jumped by 51.31% to -$23.3 million in 2025, then surged by 194.08% to $21.9 million in 2026.
  • Business Quant data shows PRTA's Net Cash Flow at $21.9 million in Q1 2026, -$23.3 million in Q4 2025, and -$40.6 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Vertex Pharmaceuticals 139.27 Bn 131.42 Bn 2.84 Bn 652.90 Mn
2 Regeneron Pharmaceuticals 85.55 Bn 77.56 Bn 3.93 Bn -504.30 Mn
3 Argenx Se 63.45 Bn 58.27 Bn 1.37 Bn -
4 Moderna 57.73 Bn 52.59 Bn 52.00 Mn -183.00 Mn
5 Revolution Medicines 44.08 Bn 44.08 Bn - 374.50 Mn
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 407.41 Mn
7 Alnylam Pharmaceuticals 35.14 Bn 31.84 Bn 992.69 Mn -496,000.00
8 Royalty Pharma 28.44 Bn 27.60 Bn - 225.59 Mn
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn -37.14 Mn
10 Prothena Corp Public 506.33 Mn 218.13 Mn - -41.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -41.27 Mn
Mar 31, 2026 21.93 Mn
Dec 31, 2025 -23.31 Mn
Sep 30, 2025 -40.59 Mn
Jun 30, 2025 -46.50 Mn
Mar 31, 2025 -53.45 Mn
Dec 31, 2024 -47.87 Mn
Sep 30, 2024 -44.86 Mn
Jun 30, 2024 16.26 Mn
Mar 31, 2024 -72.32 Mn
Dec 31, 2023 -52.07 Mn
Sep 30, 2023 11.79 Mn
Jun 30, 2023 -27.07 Mn
Mar 31, 2023 -24.22 Mn
Dec 31, 2022 215.64 Mn
Sep 30, 2022 -13.17 Mn
Jun 30, 2022 -34.20 Mn
Mar 31, 2022 -36.10 Mn
Dec 31, 2021 -21.00 Mn
Sep 30, 2021 198.92 Mn